Free Shipping On Orders Over $200 Within Canada!
A new clinical trial in Kingston, Ontario, is investigating whether microdosing psilocybin—taking very small, non-hallucinogenic doses of the compound found in magic mushrooms—can help people with generalized anxiety disorder (GAD). This is especially relevant so that consumers can eventually buy shrooms in Canada, where legalization is increasingly becoming a prospect in the future.
Led by researchers at the Kingston Health Sciences Centre and Queen’s University, the study is the first Phase 2 trial in Canada approved to examine psilocybin microdosing in a controlled medical setting. Unlike many psychedelic studies that use high doses capable of producing intense psychedelic experiences, this research focuses on very low daily doses (2–3 mg) designed to reduce anxiety without causing perceptual or psychological disruption.
The trial will include up to 60 participants with moderate to severe anxiety. For the first four weeks, all participants receive microdoses of psilocybin. In the second phase, they are randomly assigned to either continue receiving psilocybin or switch to a placebo. Researchers will track changes in anxiety levels, side effects, and overall functioning.
Lead investigator Dr. Claudio Soares explained that the study aims to determine whether psilocybin can provide relief without the intense “trip” associated with higher doses—an important consideration for people who may be sensitive to altered states of consciousness. Researchers also hope to identify whether microdosing can help people who do not respond well to traditional treatments such as antidepressants or therapy.
Interest in psychedelic medicine has surged in Canada, and rates of anxiety disorders have more than doubled over the past decade. While anecdotal reports of microdosing are widespread, this study is one of the first controlled efforts to rigorously test its safety and effectiveness.
Beyond potential clinical benefits, the researchers say the study also aims to reduce stigma around psychedelic medicine by grounding discussions in scientific evidence. By understanding how low-dose psilocybin works—and whether it truly helps—scientists hope to determine whether it could become a legitimate, regulated treatment option for anxiety in the future.
At Shroom Garden, we are committed to providing a safe option to those who are interested in exploring buying shrooms in Canada. We offer a variety of products with psilocybin mushrooms. You can choose from psilocybin dried mushrooms, microdose capsules, gummies, or chocolates.
We are committed to promoting the safe and responsible use of our products, which is why we require strict age verification before any purchase is completed. This process ensures that only adults of legal age can access our offerings, in compliance with all relevant laws and regulations. By maintaining these standards, we aim to protect younger individuals from potential harm while fostering a safe environment for informed adult consumers.
Every product we offer undergoes rigorous third-party laboratory testing to verify purity, potency, and dosage accuracy. These tests confirm that each batch is free from harmful contaminants, ensuring that customers receive only the highest-quality products. We make these results available to our consumers as part of our dedication to full transparency and trust.
If you are interested in beginning to explore your psilocybin mushrooms journey with Shroom Garden and buying shrooms in Canada, our experienced and professional customer service team is here if you wish to buy magic mushrooms in Canada. We recommend that all of users take the following precautions while using their psilocybin mushrooms products after ordering psilocybin mushrooms products online:
What are you looking for?
